Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/1996
10/02/1996EP0734444A1 Gene encoding carboxypeptidase of aspergillus niger
10/02/1996EP0734443A1 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis
10/02/1996EP0734442A1 Diagnosis of metastatic cancer by the mts-1 gene
10/02/1996EP0734441A1 Derivatives of tachyplesin having inhibitory activity towards plant pathogenic fungi
10/02/1996EP0734440A1 Tumor cell fusions and methods for use of such tumor cell fusions
10/02/1996EP0734439A1 p53-BINDING POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME
10/02/1996EP0734438A1 Method for inducing dna synthesis in neurons
10/02/1996EP0734436A1 Inhibition of dna methyltransferase
10/02/1996EP0734397A1 Apparatus and method for polymer synthesis using arrays
10/02/1996EP0734391A1 Pna-dna-pna chimeric macromolecules
10/02/1996EP0734264A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same
10/02/1996EP0734251A1 Method of transmitting a biologically active material to a cell
10/02/1996EP0734201A1 Sepsis model
10/02/1996EP0653943A4 Targeting somatic gene therapy to joints.
10/02/1996EP0597850B1 Crystalline interleukin-4
10/02/1996EP0575497B1 Dna sequences which code for virulence characteristics of -$(streptococcus suis) and parts thereof, polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by -$(s. suis) in mammals, including man
10/02/1996EP0502016B1 Novel vaccine
10/02/1996EP0485578B1 Neurotropic growth factors comprising a homeobox peptide
10/02/1996EP0458846B1 A thermostable (1,3-1,4)-beta-glucanase
10/02/1996DE19512368A1 System zur Freisetzung und Isolierung von Nukleinsäuren System for releasing and isolating nucleic acids
10/02/1996DE19512142A1 Infektiöser cDNA-Klon des Tick-Borne Enzephalitis (TBE)-Virus, davon abgeleiteter rekombinanter Impfstoff und Herstellung desselben sowie ein pharmazeutisches Produkt, das eine replizierbare Nukleinsäure enthält Infectious cDNA clone of the tick-borne encephalitis (TBE) virus derived therefrom recombinant vaccine and the preparation thereof and a pharmaceutical product containing a replicable nucleic acid
10/02/1996CN1132529A DNA sequencing enzymes
10/02/1996CN1132527A G-CSF analogue compsn. and its prepn. method
10/02/1996CN1132516A Monoclonal IgA antibody against respiratory syncytial virus
10/02/1996CN1132514A Protective antigens against parasites
10/02/1996CN1132251A Pencillin V. Amidohydrrolase gene from fusarium oxysporum
10/02/1996CN1132250A Structural method of anti-body albumen A-DNA probe
10/02/1996CN1132247A Establishment and application of GP125 gene engineering strain containing EB virus shell albumen
10/02/1996CN1132211A Process for purifying hepatitis B viral surface antigen comprising PRES2 peptide
10/01/1996US5561236 Plant cell into which a gene has been introduced, the expression of which inhibits the antibiotic and herbicidal effects of bialaphos and phosphinothricin
10/01/1996US5561224 Transcription factor for regulation of the development of skin and hair
10/01/1996US5561223 DCC protein
10/01/1996US5561064 Production of pharmaceutical-grade plasmid DNA
10/01/1996US5561063 Recombinant human cytomegalovirus containing foreign gene
10/01/1996US5561058 Methods for coupled high temperatures reverse transcription and polymerase chain reactions
10/01/1996US5561053 Dna molecule containing transcriptional regulatory regions, for genetic engineering
10/01/1996US5561044 Detection of mycobacteria by multiplex strand displacement nucleic acid amplification
10/01/1996US5561043 Genetic engineering
10/01/1996US5560929 Structured copolymers and their use as absorbents, gels and carriers of metal ions
10/01/1996CA2172659A1 Fungal cell wall protein cly4
10/01/1996CA2172305A1 Multiple antigenic peptide comprising at least two hepatitis c virus-associated peptides
10/01/1996CA1338620C Regulation of gene expression
09/1996
09/26/1996WO1996029605A2 Compounds and methods for the dectection of t. cruzi infection
09/26/1996WO1996029604A1 Method for diagnosing a patient for chlamydia
09/26/1996WO1996029431A2 Dna diagnostics based on mass spectrometry
09/26/1996WO1996029429A1 System to detect protein-rna interactions
09/26/1996WO1996029423A1 Compositions and methods for inducing infection by retroviral vectors outside of their host range
09/26/1996WO1996029422A1 Nucleic acid carrier
09/26/1996WO1996029421A1 Vectors for gene delivery
09/26/1996WO1996029420A1 Plants resistant to tospoviruses
09/26/1996WO1996029419A1 Transformed embryogenic microspores for the generation of fertile homozygous plants
09/26/1996WO1996029418A1 Introduction of dna into bacillus strains by conjugation
09/26/1996WO1996029417A1 Il-13 receptor specific chimeric proteins and uses thereof
09/26/1996WO1996029416A1 Aspergillus arabinofuranosidase
09/26/1996WO1996029415A1 Endo beta-1,4-glucanase from aspergillus
09/26/1996WO1996029414A1 Identification and cloning of a mobile transposon from aspergillus
09/26/1996WO1996029413A2 Dna encoding human papilloma virus type 18
09/26/1996WO1996029412A1 Proteinase k resistant surface protein of neisseria meningitidis
09/26/1996WO1996029411A1 Protein production and delivery
09/26/1996WO1996029410A1 In vivo generation of antibodies against antigens secreted in a host by transfected mel cells
09/26/1996WO1996029409A2 Rage tumor rejection antigens
09/26/1996WO1996029408A1 Il-17 receptor
09/26/1996WO1996029407A2 Cellubrevin homologs
09/26/1996WO1996029406A2 Nuclear localization factor associated with circadian rhythms
09/26/1996WO1996029405A2 MODULATORS OF ob GENE AND SCREENING METHODS THEREFOR
09/26/1996WO1996029404A1 HUMAN METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE mGluR6
09/26/1996WO1996029403A1 Bcl2 derived genetic elements associated with sensitivity to chemotherapeutic drugs
09/26/1996WO1996029402A1 Tumor marker protein for cancer risk assessment
09/26/1996WO1996029401A1 Human b-cell translocation genes-2 and 3
09/26/1996WO1996029400A1 Method for regulating the expression of a gene in a baculovirus using a retinoic acid receptor binding site, and vector therefor
09/26/1996WO1996029399A1 Antisense oligonucleotides for inhibiting helicobacter pylori activity
09/26/1996WO1996029398A1 Delivery and expression of heterologous genes using upstream enhancer regions of mammalian gene promoters
09/26/1996WO1996029397A1 Novel endoglucanases
09/26/1996WO1996029396A1 Recombinant infectious laryngotracheitis virus and uses thereof
09/26/1996WO1996029395A1 Cell culture method
09/26/1996WO1996029393A1 Recombinant human immunodeficiency virus-producing cell
09/26/1996WO1996029391A1 Host cell expressing reduced levels of a metalloprotease and methods using the host cell in protein production
09/26/1996WO1996029344A1 Insulin derivatives
09/26/1996WO1996029341A1 Human stat4
09/26/1996WO1996029338A1 Identification of gene mutations associated with congenital lipoid adrenal hyperplasia
09/26/1996WO1996029337A1 Thiono triester modified antisense oligodeoxynucleotide phosphorothioates
09/26/1996WO1996029097A1 Stem-loop and circular oligonucleotides
09/26/1996WO1996029096A1 Gene transfer preparation
09/26/1996WO1996029091A1 Treatment of papillomavirus-associated lesions using interleukin-12
09/26/1996WO1996028967A1 Transgenic non-primatal mammals wherein serotypes of higher primates have been expressed by foreign gene transfer and method of creating the same
09/26/1996WO1996028966A1 Transformant of nonprimatial mammal having serotype of advanced primate expressed by foreign gene transduction and process for producing the same
09/26/1996WO1996024686A3 Detection of bacteria of genus listeria using nucleic probe hybridisation techniques
09/26/1996WO1996023079A3 Method for suppressing dna fragment amplification during pcr
09/26/1996WO1996023071A3 MONOCLONAL ANTIBODIES SPECIFIC FOR DIFFERENT EPITOPES OF HUMAN gp39 AND METHODS FOR THEIR USE IN DIAGNOSIS AND THERAPY
09/26/1996WO1996023070A3 HUMAN RETINOID X RECEPTOR - GAMMA (hRXR-GAMMA)
09/26/1996WO1996023065A3 Inhibition of neovascularization using vegf-specific oligonucleotides
09/26/1996WO1996021014A3 Production and administration of high titer recombinant retroviruses
09/26/1996WO1996017924A3 Novel hedgehog-derived polypeptides
09/26/1996WO1996011272A3 Papilloma virus-like particles, fusion proteins and process for producing the same
09/26/1996CA2216597A1 Method for regulating the expression of a gene in a baculovirus using a retinoic acid receptor binding site, and vector therefor
09/26/1996CA2216284A1 Thiono triester modified antisense oligodeoxynucleotide phosphorothioates
09/26/1996CA2216147A1 Cellubrevin homologs
09/26/1996CA2216139A1 Recombinant infectious laryngotracheitis virus and uses thereof
09/26/1996CA2215730A1 Human metabotropic glutamate receptor subtype mglur6
09/26/1996CA2215694A1 Insulin derivatives